Compass Pathways (CMPS) Potential Lead in Psychedelic Sector

A couple of companies in the Magic Mushroom sector that are worth talking about are Compass Pathways (CMPS) and Minerco, Inc. (MINE). CMPS is ahead in the race is already working on a formulation of psilocybin to help with treatment-resistant depression.

By |2021-04-03T16:55:49-08:00April 3, 2021|Articles & News, Cannabis, Magic Mushrooms|0 Comments

The Ultimate Guide to 4-ACO-DMT, Experience, Benefits & Side Effects

4-AcO-DMT (or psilacetin) is a semi-synthetic tryptamine closely related to the psychedelic mushroom molecules psilocin and psilocybin. In fact, 4-AcO-DMT is widely known as “synthetic mushrooms.” Like psilocybin, it appears that the body metabolizes 4-AcO-DMT into psilocin.

By |2021-03-31T12:00:48-08:00March 7, 2021|4-AcO-DMT, 5-MEO-DMT, DMT|0 Comments

The Psilocybin Patent Race Is On

Earlier this week, NeonMind (NMDBF) filed for four provisional patents. Psilocybin Alpha said, "The provisional patent applications include data derived from NeonMind's initial preclinical trial that began in November 2020, which examined the potential use of psilocybin as a treatment for weight loss.

By |2021-03-07T12:51:17-08:00March 7, 2021|Articles & News, Magic Mushrooms|0 Comments

Field Trip Health’s New Psilocybin Research Facility Probes the Secrets of Shrooms

“Clinical studies on psilocybin and other plant-based psychedelic compounds have shown that they have great potential to produce profoundly positive changes in individuals, particularly those struggling from serious mental health conditions like anorexia, depression, and PTSD,”

By |2021-02-28T22:21:33-08:00February 28, 2021|Magic Mushrooms, Studies|0 Comments

The Next Revolution in Antidepressants Is Here – LSD, Psilocybin, MDMA, Ketamine & DMT

Psychedelic drugs essentially work opposite of an SSRI. While an SSRI inhibits serotonin processing in the brain to keep a more steady supply, psychedelics flood the brain’s neurotransmitters with chemical compounds present in the drugs that are similar to serotonin.

By |2021-02-28T20:38:41-08:00February 28, 2021|DMT, Ketamine, LSD, Magic Mushrooms, MDMA, Microdosing|0 Comments

Forget Cannabis – Psilocybin May be the Next Big Opportunity

Psygen is a Calgary-based company specializing in the synthetic manufacture of psychedelic medicines. The company provides non-exclusive access to psychedelic drug products for clinical research, therapeutic applications and is a leading supplier for the emerging commercial market.

Psychedelic Drugs Market 2021 Worth Observing Growth | Global Players – Klarisana, AstraZeneca, F. Hoffmann-La Roche, Dr. Reddy’s Laboratories

The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market.

Edmonton Psychiatry Professor Aims to Treat Mental Illness With Psychedelics Via New Company

Silverstone said where psychedelics are legal, private clinics are beginning to offer them but charge several thousand dollars. His clinic and online resource would make psychedelics more accessible.

By |2021-02-21T22:41:18-08:00February 21, 2021|Articles & News, Magic Mushrooms|0 Comments

Psychedelic Drug Therapy Now Offered at Calgary Clinic, The First Of Its Kind in Alberta

Currently, Health Canada grants exemptions that allow for individual therapy sessions using psilocybin for the terminally ill. The new clinic will start with this mandate, but Harder hopes to see it expand.

By |2021-02-20T02:08:31-08:00February 20, 2021|Articles & News, Magic Mushrooms|0 Comments

Hawaiian Lawmakers Consider Legalizing ‘Magic Mushrooms’ in Treatment Settings

The situation has prompted lawmakers to consider a measure that would remove psilocybin from the list of Schedule 1 substances, which includes heroin, LSD and ecstasy.

By |2021-02-20T01:36:42-08:00February 20, 2021|Magic Mushrooms, MDMA, Psychedelic News|0 Comments
Go to Top